330 related articles for article (PubMed ID: 35549675)
1. Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections.
Fluit AC; Bayjanov JR; Aguilar MD; Cantón R; Elborn S; Tunney MM; Scharringa J; Benaissa-Trouw BJ; Ekkelenkamp MB
BMC Microbiol; 2022 May; 22(1):129. PubMed ID: 35549675
[TBL] [Abstract][Full Text] [Related]
2.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
3. Delineation of Stenotrophomonas maltophilia isolates from cystic fibrosis patients by fatty acid methyl ester profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectra using hierarchical cluster analysis and principal component analysis.
Vidigal PG; Mosel F; Koehling HL; Mueller KD; Buer J; Rath PM; Steinmann J
J Med Microbiol; 2014 Dec; 63(Pt 12):1615-1620. PubMed ID: 25266870
[TBL] [Abstract][Full Text] [Related]
4. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.
Mojica MF; Rutter JD; Taracila M; Abriata LA; Fouts DE; Papp-Wallace KM; Walsh TJ; LiPuma JJ; Vila AJ; Bonomo RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31266860
[No Abstract] [Full Text] [Related]
5. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants.
Nicoletti M; Iacobino A; Prosseda G; Fiscarelli E; Zarrilli R; De Carolis E; Petrucca A; Nencioni L; Colonna B; Casalino M
Int J Med Microbiol; 2011 Jan; 301(1):34-43. PubMed ID: 20952251
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Jahnke N; Waters V
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Stenotrophomonas maltophilia isolates from cystic fibrosis patients in Russia.
Bocharova YA; Savinova TA; Lyamin AV; Kondratenko OV; Polikarpova SV; Zhilina SV; Fedorova NI; Semykin SY; Chaplin AV; Korostin DO; Mayansky NA; Chebotar IV
Klin Lab Diagn; 2022 May; 67(5):315-320. PubMed ID: 35613352
[TBL] [Abstract][Full Text] [Related]
9.
Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
[No Abstract] [Full Text] [Related]
10. Genomic information on Stenotrophomonas maltophilia ST264 isolated from a cystic fibrosis pediatric patient in Brazil.
Braga FS; D'Allincourt Carvalho Assef AP; Leão RS; Albano RM; Marques EA
Braz J Microbiol; 2020 Sep; 51(3):1125-1127. PubMed ID: 31858443
[TBL] [Abstract][Full Text] [Related]
11. Detection of multidrug resistant environmental isolates of
Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
[No Abstract] [Full Text] [Related]
12. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2014 Apr; (4):CD009249. PubMed ID: 24696136
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Amin R; Waters V
Cochrane Database Syst Rev; 2012 May; (5):CD009249. PubMed ID: 22592739
[TBL] [Abstract][Full Text] [Related]
14.
Alcaraz E; Garcia C; Papalia M; Vay C; Friedman L; Passerini de Rossi B
J Med Microbiol; 2018 Jul; 67(7):992-1002. PubMed ID: 29799387
[No Abstract] [Full Text] [Related]
15. Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis.
Di Bonaventura G; Prosseda G; Del Chierico F; Cannavacciuolo S; Cipriani P; Petrucca A; Superti F; Ammendolia MG; Concato C; Fiscarelli E; Casalino M; Piccolomini R; Nicoletti M; Colonna B
Int J Immunopathol Pharmacol; 2007; 20(3):529-37. PubMed ID: 17880766
[TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia: An Urgent Threat with Increasing Antibiotic Resistance.
Liu J; Xiang Y; Zhang Y
Curr Microbiol; 2023 Nov; 81(1):6. PubMed ID: 37955756
[TBL] [Abstract][Full Text] [Related]
17. Impaired Airway Epithelial Barrier Integrity in Response to
Molloy K; Cagney G; Dillon ET; Wynne K; Greene CM; McElvaney NG
Front Immunol; 2020; 11():198. PubMed ID: 32161586
[No Abstract] [Full Text] [Related]
18. Review on
Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
[TBL] [Abstract][Full Text] [Related]
19. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
20. The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction.
Alcaraz E; García C; Friedman L; de Rossi BP
FEMS Microbiol Lett; 2019 Mar; 366(6):. PubMed ID: 31044250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
